Calcified Tissue International

, Volume 93, Issue 1, pp 69–77 | Cite as

The Effect of High-Dose Vitamin D Supplementation on Calciotropic Hormones and Bone Mineral Density in Obese Subjects with Low Levels of Circulating 25-Hydroxyvitamin D: Results from a Randomized Controlled Study

  • Louise WambergEmail author
  • Steen B. Pedersen
  • Bjørn Richelsen
  • Lars Rejnmark
Original Research


Low levels of 25-hydroxyvitamin D (25OHD) are associated with increased bone turnover and risk of fractures. Plasma 25OHD is inversely related to body mass index, and vitamin D deficiency is common in obesity. We aimed to determine whether vitamin D supplementation affects bone turnover and bone mineral density (BMD) in obese subjects. Fifty-two healthy obese men and women aged 18–50 years with plasma 25OHD levels below 50 nmol/L were randomized to 7,000 IU of cholecalciferol daily or placebo for 26 weeks. We measured plasma levels of 25OHD, parathyroid hormone (PTH), and markers of bone turnover, as well as BMD at the hip, spine, forearm, and whole body. Compared with placebo, treatment with cholecalciferol increased mean plasma 25OHD from 35 to 110 nmol/L (p < 0.00001) and significantly decreased PTH (p < 0.05). BMD increased significantly at the forearm by 1.6 ± 0.7 % (p = 0.03). The bone resorption marker C-terminal telopetide of type 1 collagen (CTX) decreased borderline significantly in the cholecalciferol group compared with the placebo group (p = 0.07). Changes in plasma 25OHD correlated inversely with changes in plasma levels of bone-specific alkaline phosphatase (r = −0.38, p = 0.01) and CTX (r = −0.33, p = 0.03). Changes in CTX correlated inversely with changes in spine BMD (r = −0.45, p = 0.04). Increasing circulating 25OHD levels by cholecalciferol treatment is of importance to bone health in young obese subjects as increased levels of 25OHD are associated with a decrease in both PTH and bone turnover and with an increase in BMD at the forearm.


Obesity Vitamin D Parathyroid hormone Bone turnover Bone mineral density Randomized controlled trial 


  1. 1.
    Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8(5):567–573PubMedCrossRefGoogle Scholar
  2. 2.
    De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJ 3rd, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16(11):1330–1338PubMedCrossRefGoogle Scholar
  3. 3.
    Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early postmenopausal intervention cohort (EPIC) study group. J Bone Miner Res 14(9):1622–1627PubMedCrossRefGoogle Scholar
  4. 4.
    Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF (1992) Determinants of total body and regional bone mineral density in normal postmenopausal women—a key role for fat mass. J Clin Endocrinol Metab 75(1):45–51PubMedCrossRefGoogle Scholar
  5. 5.
    Premaor MO, Ensrud K, Lui L, Parker RA, Cauley J, Hillier TA, Cummings S, Compston JE (2011) Risk factors for nonvertebral fracture in obese older women. J Clin Endocrinol Metab 96(8):2414–2421PubMedCrossRefGoogle Scholar
  6. 6.
    Compston JE, Watts NB, Chapurlat R, Cooper C, Boonen S, Greenspan S, Pfeilschifter J, Silverman S, Diez-Perez A, Lindsay R, Saag KG, Netelenbos JC, Gehlbach S, Hooven FH, Flahive J, Adachi JD, Rossini M, Lacroix AZ, Roux C, Sambrook PN, Siris ES, Glow I (2011) Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 124(11):1043–1050PubMedCrossRefGoogle Scholar
  7. 7.
    Nielson CM, Marshall LM, Adams AL, LeBlanc ES, Cawthon PM, Ensrud K, Stefanick ML, Barrett-Connor E, Orwoll ES, Osteoporotic Fractures in Men Study Research Group (2011) BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res 26(3):496–502PubMedCrossRefGoogle Scholar
  8. 8.
    Friedmann JM, Elasy T, Jensen GL (2001) The relationship between body mass index and self-reported functional limitation among older adults: a gender difference. J Am Geriatr Soc 49(4):398–403PubMedCrossRefGoogle Scholar
  9. 9.
    Fjeldstad C, Fjeldstad AS, Acree LS, Nickel KJ, Gardner AW (2008) The influence of obesity on falls and quality of life. Dyn Med 7:4PubMedCrossRefGoogle Scholar
  10. 10.
    Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD (2009) Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 94(9):3387–3393PubMedCrossRefGoogle Scholar
  11. 11.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930PubMedCrossRefGoogle Scholar
  12. 12.
    Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P (2009) Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 24(4):693–701PubMedCrossRefGoogle Scholar
  13. 13.
    Jorde R, Sneve M, Torjesen P, Figenschau Y, Hansen JB, Grimnes G (2010) No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year. Nutr J 9(1):1PubMedCrossRefGoogle Scholar
  14. 14.
    Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51(9):1683–1690PubMedCrossRefGoogle Scholar
  15. 15.
    Hojskov CS, Heickendorff L, Moller HJ (2010) High-throughput liquid–liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin Chim Acta 411(1–2):114–116PubMedCrossRefGoogle Scholar
  16. 16.
    Rosenquist C, Qvist P, Bjarnason N, Christiansen C (1995) Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 41(10):1439–1445PubMedGoogle Scholar
  17. 17.
    Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen SB, Richelsen B (2013) Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels—Results from a randomized trial. Eur J Intern Med. doi: 10.1016/j.ejim.2013.03.005
  18. 18.
    Abraha I, Montedori A (2010) Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ 340:c2697PubMedCrossRefGoogle Scholar
  19. 19.
    Frame B, Parfitt AM (1978) Osteomalacia: current concepts. Ann Intern Med 89(6):966–982PubMedCrossRefGoogle Scholar
  20. 20.
    Rejnmark L, Vestergaard P, Brot C, Mosekilde L (2008) Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics. Clin Endocrinol (Oxf) 69(1):29–35CrossRefGoogle Scholar
  21. 21.
    Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34(11):2359–2363PubMedGoogle Scholar
  22. 22.
    Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M (2011) Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 96(5):1320–1326PubMedCrossRefGoogle Scholar
  23. 23.
    Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, Acton A, Considine RV, Peacock M (2012) Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 97(5):1655–1662PubMedCrossRefGoogle Scholar
  24. 24.
    Diamond T, Wong YK, Golombick T (2013) Effect of oral cholecalciferol 2, 000 versus 5, 000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int 24:1101–1105PubMedCrossRefGoogle Scholar
  25. 25.
    Prestwood KM, Pannullo AM, Kenny AM, Pilbeam CC, Raisz LG (1996) The effect of a short course of calcium and vitamin D on bone turnover in older women. Osteoporos Int 6(4):314–319PubMedCrossRefGoogle Scholar
  26. 26.
    Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier PJ (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13(3):257–264PubMedCrossRefGoogle Scholar
  27. 27.
    Zhu K, Devine A, Dick IM, Wilson SG, Prince RL (2008) Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab 93(3):743–749PubMedCrossRefGoogle Scholar
  28. 28.
    Vilarrasa N, San Jose P, Garcia I, Gomez-Vaquero C, Miras PM, de Gordejuela AG, Masdevall C, Pujol J, Soler J, Gomez JM (2011) Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg 21(4):465–472PubMedCrossRefGoogle Scholar
  29. 29.
    Tsiftsis D, Mylonas P, Mead N, Kalfarentzos F, Alexandrides T (2009) Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss? Obes Surg 19(11):1497–1503PubMedCrossRefGoogle Scholar
  30. 30.
    Ehrlich PJ, Lanyon LE (2002) Mechanical strain and bone cell function: a review. Osteoporos Int 13(9):688–700PubMedCrossRefGoogle Scholar
  31. 31.
    Pedersen A, Fagt S, Groth MV, Christensen T, Biltoft-Jensen A, Matthiessen J, Andersen NL, Kørup K, Hartkopp H, Ygil KH, Hinsch H, Saxholt E, Trolle E (2010) Dietary habits in Denmark 2003–2008. Main results. DTU Fødevareinstituttet, LyngbyGoogle Scholar
  32. 32.
    Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF (1998) Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8(3):222–230PubMedCrossRefGoogle Scholar
  33. 33.
    Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77(1):204–210PubMedGoogle Scholar
  34. 34.
    Gallagher JC, Sai A, Templin T II, Smith L (2012) Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med 156(6):425–437PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Louise Wamberg
    • 1
    • 2
    Email author
  • Steen B. Pedersen
    • 1
    • 2
  • Bjørn Richelsen
    • 1
    • 2
  • Lars Rejnmark
    • 1
    • 2
  1. 1.Department of Endocrinology and Internal Medicine MEAAarhus University HospitalAarhusDenmark
  2. 2.Institute of Clinical Medicine, Aarhus UniversityAarhusDenmark

Personalised recommendations